Drug Trial Radar · NCT01280058
Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer
Last checked: Nov 19, 2026Latest source record: Mar 9, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
73
Actual
Start
Dec 2010
Primary completion
Jan 19, 2016
Study completion Jan 20, 2016
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- First posted
- Jan 20, 2011
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase II trial studies how well carboplatin and paclitaxel with or without viral therapy works in treating patients with pancreatic cancer that has come back or has spread to other places in the body. Drugs used in chemotherapy, such as carboplatin and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Viral therapy may be able to kill tumor cells without damaging normal cells. It is not yet known whether carboplatin and paclitaxel are more effective with or without viral therapy in treating pancreatic cancer.
Conditions
- Pancreatic Acinar Cell Carcinoma
- Pancreatic Ductal Adenocarcinoma
- Recurrent Pancreatic Carcinoma
- Stage IV Pancreatic Cancer
Interventions
CarboplatinDrug
Given IV
Laboratory Biomarker AnalysisOther
Correlative studies
PaclitaxelDrug
Given IV
Wild-type ReovirusBiological
Given IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free Survival Using RECIST v. 1.1Time frame: From study entry to the date of documented progression and/or death, assessed up to 4 years
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
MedStar Georgetown University Hospital
Washington D.C., District of Columbia
Emory University/Winship Cancer Institute
Atlanta, Georgia
Montefiore Medical Center-Weiler Hospital
The Bronx, New York
Montefiore Medical Center - Moses Campus
The Bronx, New York
Ohio State University Comprehensive Cancer Center
Columbus, Ohio
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.